Single Ketamine Infusion May Relieve Severe Depression Within Hours, Study Finds
A growing body of research suggests that ketamine, a drug originally developed as an anesthetic, may provide rapid relief for people suffering from severe depression and suicidal thoughts.
Researchers from the University of Connecticut School of Medicine reviewed 26 clinical trials involving more than 1,100 patients to better understand ketamine’s effects on depression. Their findings showed that even a single intravenous infusion could significantly reduce depressive symptoms within just four hours.
The review also found that suicidal thoughts dropped dramatically within 24 hours for many patients receiving the treatment.
### Why Researchers Are Paying Attention
Traditional antidepressants can often take several weeks before patients begin noticing meaningful improvement. Ketamine appears to work differently by targeting glutamate, a brain chemical linked to mood regulation, allowing effects to appear much faster in some cases.
Researchers say this rapid response could become especially important for patients experiencing psychiatric emergencies or treatment-resistant depression, where standard medications have failed.
Some experts believe ketamine infusions may offer temporary but potentially life-saving relief while patients pursue longer-term mental health treatment plans.
### Relief Often Comes Quickly, But May Not Last
Patients in the reviewed studies reported reduced depressive symptoms for up to a week after a single infusion, while suicidal thoughts sometimes remained lower for as long as a month.
However, researchers noted that many patients eventually experienced a return of symptoms, meaning repeated treatments may be necessary for some individuals.
The studies also reported side effects including dizziness, nausea, headaches, dissociation, and temporary visual disturbances. Researchers said these symptoms generally resolved within hours.
### Experts Urge Medical Supervision
Mental health specialists caution that ketamine should only be administered under professional medical supervision due to potential risks, including misuse and addiction.
Although ketamine is increasingly being explored in psychiatric care, intravenous ketamine is not currently FDA-approved specifically for depression treatment, though doctors may prescribe it off-label in certain severe cases.
Experts also stressed that ketamine is not considered a cure for depression, but rather one possible option for carefully selected patients who have not responded to conventional therapies.
### Study Highlights Growing Interest In Alternative Treatments
Major depressive disorder affects hundreds of millions of people worldwide, and researchers continue searching for faster and more effective treatments for severe cases.
While scientists say more long-term research is still needed, the latest findings add to growing evidence that ketamine could play an important role in emergency mental health care for some patients struggling with suicidal thoughts or treatment-resistant depression.
Doctors advise anyone considering alternative depression treatments to first consult licensed healthcare professionals to fully understand the potential benefits and risks involved.
